Missiles to Medicine: Pharmacy Alum Gives Back to Nuclear Program

There are very few people in the world who can claim to turn missiles into medicine but John Zehner (BS ’91) is among them.

Zehner, a nuclear pharmacist, is partner and CEO of SpectronRx, a contract manufacturing and development organization that specializes in radiopharmaceuticals. In 2027, when Purdue’s new Nursing and Pharmacy Education Building opens, the nuclear pharmacy lab will be outfitted with state-of-the-art equipment because of Zehner’s generosity on Purdue Day of Giving.

Alumna overcomes adversity, honors late professor husband with endowment

The FOE—Friends of Emily, for those not yet in the know—refer to Dr. Emily Hancock (PharmD ’92) as the EOF: Epicurean of Fun.

It’s a title she happily embraces, but it’s also a title that’s far from telling the whole story of who she is. Emily, the widow of former Purdue University College of Pharmacy Professor Bruce Hancock (BS ’75, MS ’77), says she grew up with a mother who could make even the most mundane tasks feel like a good time—a perspective Emily has held tight to even in the depths of unimaginable adversity.

Genetically engineering a treatment for incurable brain tumors

Purdue researchers develop fully off-the-shelf, stem cell-derived, natural killer cells against glioblastoma

WEST LAFAYETTE, Ind. — Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma. 

Born a Boilermaker: Alumnus John Voliva’s story of family, pharmacy, and philanthropy

John Voliva during the podcast interview )" aria-label="">

Podcast episode : Born a Boilermaker: Alumnus John Voliva’s story of family, pharmacy, and philanthropy

 

Subscribe to our podcast!

Growing up in a family with a legacy in pharmacy and at Purdue, it was only natural for John Voliva to pursue the same path.

Voliva’s great grandfather, John A. Hook, was the founder of Hook’s Drug Stores, an Indiana-based chain founded in 1900 that eventually spread throughout the Midwest.


Solid foundations for world-changing medicines and vaccines

Purdue scientist stabilizes pharmaceuticals to improve storage, stability and extend shelf life

WEST LAFAYETTE, Ind. — Pharmaceuticals are an important foundation of modern health and society. Without vaccines, medications and therapeutics, civilization as we know it would break down. And without careful formulation and storage, the pharmaceuticals themselves can break down and decay into uselessness.

Understanding and preventing that decay is the focus of Purdue scientist Elizabeth Topp’s career. 

Zhou receives $2.4M to fight antimicrobial resistance

Tony Zhou, associate professor of industrial and molecular pharmaceutics, recently received a third National Institutes of Health (NIH) grant to support his world-leading research program in developing novel inhalation therapeutics fighting antimicrobial resistance.

The $2.4 million grant was awarded to Zhou to lead a multi-national team of top antimicrobial experts from Australia, Thailand, and the US, to fight the issue.

Former dean names professorship; Flaherty appointed

Chip Rutledge knows the importance of flexible funds to support early career professors in establishing their research programs.

The former dean of the former College of Pharmacy, Nursing, and Health Sciences at Purdue, alongside his wife Jane, recently established the Chip and Jane Rutledge Early Career Professorship to support young professors as they develop their academic programs.